arrow
返回

Cannabinoids: Emerging sleep modulator

delete2023-09-01
delete4
delete
OA
AI
Z
Zhen Xuen Brandon Low
X
Xin Ru Lee
T
Tomoko Soga
B
Bey Hing Goh
D
Deepa Alex
Y
Yatinesh Kumari *
DOI:10.1016/j.biopha.2023.115102delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Sleep is an essential biological phase of our daily life cycle and is necessary for maintaining homeostasis, alertness, metabolism, cognition, and other key functions across the animal kingdom. Dysfunctional sleep leads to deleterious effects on health, mood, and cognition, including memory deficits and an increased risk of diabetes, stroke, and neurological disorders. Sleep is regulated by several brain neuronal circuits, neuromodulators, and neurotransmitters, where cannabinoids have been increasingly found to play a part in its modulation. Cannabinoids, a group of lipid metabolites, are regulatory molecules that bind mainly to cannabinoid receptors (CB1 and CB2). Much evidence supports the role of cannabinoid receptors in the modulation of sleep, where their alteration exhibits sleep-promoting effects, including an increase in non-rapid-eye movement sleep and a reduction in sleep latency. However, the pharmacological alteration of CB1 receptors is associated with adverse psychotropic effects, which are not exhibited in CB2 receptor alteration. Hence, selective alteration of CB2 receptors is also of clinical importance, where it could potentially be used in treating sleep disorders. Thus, it is crucial to understand the neurobiological basis of cannabinoids in sleep physiology. In this review article, the alteration of the endocannabinoid system by various cannabinoids and their respective effects on the sleep-wake cycle are discussed based on recent findings. The mechanisms of the cannabinoid receptors on sleep and wakefulness are also explored for their clinical implications and potential therapeutic use on sleep disorders.
Keyword:
CB1
CB2
Circadian rhythm
Endocannabinoid system
Sleep
Sleep disorder
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

B
Biomedicine and Pharmacotherapy
IF:
7.5
论文数:
1.6W
被引数:
8.2W

机构

M
Monash University
学者数:
5.4W
论文数: 5.4W
被引数: 79
Monash University Malaysia 封面图
Monash University Malaysia
学者数:
3.1K
论文数: 2.9K
被引数: 5.4K
引用论文

引用论文

Exposure to the cannabinoid agonist WIN 55, 212-2 in adolescent rats causes sleep alterations that persist until adulthood
err2020-05-01
err10
PREAI
errMacias-Triana, Lorena; Romero-Cordero, Karen; Tatum-Kuri, Agnes; Vera-Barron, Alba; Millan-Aldaco, Diana; Arankowsky-Sandoval, Gloria; Piomelli, Daniele; Murillo-Rodriguez, Eric
err分享
err收藏
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
err2009-01-29
err666
errOAAI
errThomas, A.; Baillie, G. L.; Phillips, A. M.; Razdan, R. K.; Ross, R. A.; Pertwee, R. G.
err分享
err收藏
err分享
err收藏
Gastric tonometry and direct intraabdominal pressure monitoring in abdominal compartment syndrome
err2002-02-01
err0
PREAI
errS.A. Engum; B. Kogon; E. Jensen; J. Isch; C. Balanoff; J.L. Grosfeld
err分享
err收藏
Metagenomic analysis of bronchoalveolar lavage samples from patients with idiopathic interstitial pneumonia and its antagonic relation with Pneumocystis jirovecii colonization
err2010-07-01
err0
PREAI
errVicente Friaza; Carmen de la Horra; Mario J. Rodríguez-Domínguez; José Martín-Juan; Rafael Cantón; Enrique J. Calderón; Rosa del Campo
err分享
err收藏
Glomerular Volume in Congestive Cardiac Failure
err1997-01-01
err0
PREAI
errJames D. Walker; Barbara Burke; Michael W. Steffes; Michael Mauer
err分享
err收藏
err分享
err收藏
err分享
err收藏
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP
err2017-07-06
err74
errOAAI
errViveros-Paredes, Juan M.; Gonzalez-Castaneda, Rocio E.; Gertsch, Juerg; Chaparro-Huerta, Veronica; Lopez-Roa, Rocio I.; Vazquez-Valls, Eduardo; Beas-Zarate, Carlos; Camins-Espuny, Antoni; Flores-Soto, Mario E.
err分享
err收藏
学者 查看更多内容